A request by Republicans for the Supreme Court to hear the case is pending. Despite its statement, Jones Day has faced criticism, which some attorneys have spoken out against, arguing that a tenet of law firm business and the U.S. legal system is that even controversial clients deserve counsel. …read more […]
Montreal, Quebec–( – November 12, 2020) – Peak Positioning Technologies Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that its Cubeler Lending […]
“We could lock down for four to six weeks and if we did that, we could drive the numbers down,” Dr. Michael Osterholm, a Biden task force doctor, says. …read more […]
Amikacin receives Health Canada approval, commercialization to start in first half of 2021 Strong start for Ethacrynate Sodium commercialization in the U.S. Heightened commercial and scientific interest in Hesperco™ preceeds retail launch Strong fourth quarter […]
Audience Measurement, Content Management and Security Software Included in New Bundled Offering Philadelphia, PA, Nov. 12, 2020 — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and […]
Health spending in Canada was approximately $264 billion in 2019, 30% represents private-sector spending1 One of the main pain points for employers and insurers is the multiple vendors required to cover the spectrum of healthcare services CloudMD delivers one centralized platform that addresses access […]
The news comes days after early-stage data showed Medicago’s plant-based vaccine candidate produced virus-fighting antibodies in all volunteers. Medicago, backed by cigarette maker Philip Morris International, is Canada’s most advanced COVID-19 vaccine project, but lags larger, global rivals. Medicago has said a lower dose of the vaccine will be used for further trials, for which Dynavax Technologies’ adjuvant will not be used as before. …read more […]
(Bloomberg Opinion) — After five states — Arizona, Mississippi, Montana, New Jersey and South Dakota — passed ballot measures for marijuana use last week, the drug will soon be legal in some form for 70% of the U.S. population. A third of the country won’t even need a medical excuse. But that’s not the surprise.What’s more notable is that unlike in the past, all of this happened without much of a public uproar. To be fair, there have been bigger concerns on Americans’ minds these days. But this is the moment that cannabis companies and their investors have been waiting …read more […]
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) just released its third-quarter report and things are looking bullish. Sales… …read more […]
Online retailers have largely benefited from the COVID-19 pandemic, as individuals staying home use e-commerce platforms like Alibaba, Pinduoduo and JD.com to purchase everything from groceries to electric appliances. Non-GAAP net profit, reported for the first time since the company’s listing in 2018, was 466.4 million yuan compared with a loss of 1.66 billion yuan a year before. “This is a milestone,” said Natalie Wu, internet analyst at Haitong International Securities. …read more […]
Regular readers will know that we love our dividends at Simply Wall St, which is why it’s exciting to see Valero… …read more […]
The International Air Transport Association is calling on governments and airlines worldwide to prepare for a global armada to deliver coronavirus vaccine. …read more […]
* WELL achieved another record quarter for Q3-2020 with revenue of $12,245,735 and record Gross profit(1) of $5,045,440, representing 50% and 75% year-over-year (“YoY”) growth respectively. Coupled with recently completed and announced acquisitions, WELL is currently on a ~$68M annualized revenue run-rate and growing quickly. …read more […]
Experts are urging the American public to continue following public health guidelines, including mask wearing and social distancing. …read more […]
Stock futures were mostly lower Thursday morning, with contracts on the Dow and S&P 500 sliding as optimism over a COVID-19 vaccine moderated further. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
